ARCHIVES

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

This article is from The Cancer Letter archive.

Vol. 38 No. 19 | May 11, 2012

Download PDF Visit The Full Archive

Related Articles

Disease Oriented Programs Must Be Coordinated: Rabson

October 15, 1976

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

Alternative Medicine Officer Awards 30 Research Grants

October 15, 1993

Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach

February 7, 2014